Wednesday tips round-up: Genus, Ashtead, Dechra
5th Sep 2012 07:20
In The Times, the Tempus column kicks off with animal semen producer Genus, which dropped yesterday as investors worried about the price of feedstocks like corn in the agricultural sector. But Genus has been a major success story, providing the gene pool to increase yields for pig and cow farmers ac
Read moreLondon pre-open: Stocks cautious after Moody's lowers EU outlook
4th Sep 2012 07:32
London's Footsie is expected to open just a few points lower than yesterday's close of 5,758 after Moody's lowered the European Union's outlook. Credit ratings agency Moody's last night maintained the EU's 'Aaa' rating but lowered its outlook for the region from 'stable' to 'negative' to reflect "t
Read moreUS drought may slow demand for Genus's services
4th Sep 2012 07:14
Record results from Genus, the animal genetics company, topped full-year sales and profits expectations but this year may prove tougher as farmers deal with the effects of the US drought. Revenue in the year to June 30th rose 10%, or 12% in constant currency (CC) terms, to £341.8m from £309.9m the
Read moreTuesday preview: Genus, Dechra, Greene King
3rd Sep 2012 16:34
Tuesday has a bit of an agricultural feel to it, with animal genetics company Genus and veterinary health-care company Dechra Pharmaceuticals set to update the market. Peel Hunt says emerging markets growth should be offsetting higher feed prices at Genus. It is forecasting a 15% improvement in pr
Read moreWeek Ahead: Central banks, Morrisons, Genus
31st Aug 2012 09:48
Central bank decisions will be in focus next week, particularly in the wake of the central bankers' economic symposium in Jackson Hole. Indeed, so busy is European Central Bank (ECB) President Mario Draghi preparing for next week's meeting that he has been unable to attend the jolly-up in the Wyomi
Read moreGenus forms JV to expand its market share in China
31st Jul 2012 08:53
Genus, a global animal genetics company, has said that its porcine genetics division, PIC, has signed a joint venture (JV) agreement with Shaanxi Yangling BeSun Agricultural Group, an integrated pork producer in China, to partner in the operation of a large 4,250 sow nucleus farm in China's Shaanxi
Read moreTuesday broker round-up
24th Jul 2012 08:15
Aberdeen Asset Management: Societe Generale upgrades to buy from hold. Aggreko: S&P Equity Research upgrades to buy. BT Group: Societe Generale raises target from 210p to 220p, hold rating kept. CareTech: Canaccord Genuity ups target from 166p to 194p, buy rating kept. Carpetright: Merchant Secu
Read moreLondon pre-open: Small declines forecast for FTSE
4th Jul 2012 07:34
City sources predict the FTSE 100 will open down 12 points from yesterday's close of 5,688, with little guidance from the US following a half day of trading. Echoing statements made by sector peer Persimmon on Tuesday, house builder Taylor Wimpey said the first half of 2012 was a stable one for th
Read moreGenus comes in on track
4th Jul 2012 07:08
Genus, the global animal genetics company, said its full year figures would be in line with expectations after a good performance over the last two months. The company said pricing had remained firm, with adjusted operating profit improving in line with expectations despite increasing investment in
Read moreWednesday preview: Carillion, Genus, Topps Tiles
3rd Jul 2012 17:56
Tomorrow is Independence Day in the USA, so US markets will be closed but there should be plenty of news back in Blighty to keep traders occupied. Support services firm Carillion brings out a pre-close trading statement. Broker Peel Hunt says it is concerned that Middle East construction, which acc
Read moreGenus aims to pig out in China
3rd May 2012 08:33
Pig and bovine semen seller Genus says customers have faced modest pressure in March and April but the first four months of the year have proceeded broadly in line with expectations. Genus's business model is based on providing the best genes to each market to increase productivity both in meat vol
Read moreGenus Finance Director sells 43,000 shares
14th Mar 2012 15:32
John Worby, Group Finance Director of Genus, the FTSE 250 animal genetics firm, has sold 43,000 shares, half of the amount he vested earlier this month. Worby sold 43,261 shares at 1,318.41p each for a total of £570,357. The sale was made further to the vesting of 86,523 conditional nil-cost share
Read moreSSE director sells 1,000 shares
21st Feb 2012 16:04
Jim McPhillimy, the Managing Director of Group Services at energy firm SSE, has sold off 1,000 shares in the firm for 1,289.00p each. The sale comes three weeks after the company said it was on course to deliver an increase in the dividend per share and an increase in pre-tax profits for the financ
Read moreTuesday broker round-up - UPDATE
21st Feb 2012 09:00
Admiral: Nomura reiterates buy recommendation and 1,100p target; Credit Suisse upgrades to outperform from neutral, lifts target from 1,100p to 1,300p. Morrison: Goldman Sachs adds to conviction sell list. Petropavlovsk: Nomura upgrades from reduce to neutral, target upped from 860p to 910p. Aber
Read moreEmerging markets boost sales at Genus
21st Feb 2012 07:35
Strong growth in sales volumes in Asia has seen animal genetics firm Genus increase revenue by almost a tenth in the first half of its financial year. Furthermore, after reviewing its dividend policy last year, the firm has decided to start paying an interim dividend for the first time this year. T
Read more